0000000000401107

AUTHOR

Poonam Gardner-sood

showing 5 related works from this author

The Representativeness of Participants With Severe Mental Illness in a Psychosocial Clinical Trial

2018

Introduction: Cardiovascular morbidity and mortality are increased in severe mental illnesses (SMI). Trials of psychosocial health interventions to improve physical health in SMI, including in treatment-resistant schizophrenia, have shown some benefit. However, the representativeness of participants in such trials has not been determined. Method: We utilized an anonymised case register to determine if participants in a randomized controlled trial (RCT) of a novel psychosocial health intervention aiming to improve physical health in SMI had similar severity of illness to eligible non-participants. A retrospective database analysis was performed, using Health of the Nation Outcome Scale (HoNO…

medicine.medical_specialtylcsh:RC435-571PopulationPsychological interventionoutcomesHealth interventionlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawlcsh:PsychiatrySeverity of illnessMedicinepsychosiseducationOriginal Researchhealth promotion interventionPsychiatryeducation.field_of_studybusiness.industrycardiovascularMental health030227 psychiatryClinical trialschizophreniaPsychiatry and Mental healthPhysical therapybusinessPsychosocial030217 neurology & neurosurgeryFrontiers in Psychiatry
researchProduct

A health promotion intervention to improve lifestyle choices and health outcomes in people with psychosis: a research programme including the IMPaCT …

2020

Background People with psychotic disorders have reduced life expectancy largely because of physical health problems, especially cardiovascular disease, that are complicated by the use of tobacco and cannabis. Objectives We set out to (1) chart lifestyle and substance use choices and the emergence of cardiometabolic risk from the earliest presentation with psychosis, (2) develop a pragmatic health promotion intervention integrated within the clinical teams to improve the lifestyle choices and health outcomes of people with psychosis and (3) evaluate the clinical effectiveness and cost-effectiveness of that health promotion intervention. Design We performed a longitudinal cohort study of peo…

dysglycaemiamedicine.medical_specialtyhealth promotionMotivational interviewingmotivational interviewinglaw.invention03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Randomized controlled triallawIntervention (counseling)medicinepsychosis030212 general & internal medicinerctFirst episodelifestyle choicesbusiness.industrylcsh:Public aspects of medicineweightlcsh:RA1-1270waist circumferenceMental health030227 psychiatryHealth promotionquality of lifeFamily medicineLife expectancybusinessphysical healthmental healthProgramme Grants for Applied Research
researchProduct

Cannabis users have higher premorbid IQ than other patients with first onset psychosis.

2013

Background: A number of studies have reported that patients with psychosis who use cannabis have better cognitive performance than those who do not. This is surprising as cannabis can impair cognition in healthy subjects. An obvious question is whether the better current performance of psychotic patients who have used cannabis is a reflection of their having a higher premorbid IQ than those psychotic patients who haven't used cannabis. Aim: In a sample of patients at their first episode of psychosis, we tested the hypothesis that patients who smoked cannabis would have a higher premorbid IQ than patients who did not. Methodology: 279 participants (119 patients and 160 healthy controls) were…

AdultMalemedicine.medical_specialtyPsychosisMarijuana AbuseFirst Episode of Psychosis (FEP)Premorbid IQIntelligenceNeuropsychological TestsSubstance usebehavioral disciplines and activitiesYoung AdultCognitionSettore M-PSI/08 - Psicologia Clinicamental disordersmedicineHumansEffects of sleep deprivation on cognitive performanceCannabiYoung adultCannabis; Cognition; First Episode of Psychosis (FEP); IQ; Premorbid IQ; Risk of psychosis; Schizophrenia; Substance useRisk of psychosiPsychiatryBiological PsychiatryFirst episodeIntelligence TestsPsychiatric Status Rating ScalesAnalysis of VarianceChi-Square DistributionIntelligence quotientbiologymedicine.diseasebiology.organism_classificationPsychiatry and Mental healthPsychotic DisordersSchizophreniaIQSchizophreniaFemaleCannabisPsychologyhuman activitiesChi-squared distributionClinical psychology
researchProduct

Tobacco smoking and nicotine dependence in first episode and established psychosis

2019

Aim\ud People with psychotic disorders have increased premature mortality in comparison with the general population, with high rates of cigarette use a contributing factor. We aimed to describe the prevalence of cigarette use and nicotine dependence (ND) in first episode psychosis (FEP), and established psychosis; and to investigate associations between clinical symptoms and ND.\ud \ud Methodology\ud Smoking and clinical data were collected from two cohorts: 181 people with FEP recruited as part of the Physical Health and Substance Use Measures in First Onset Psychosis (PUMP) study and from 432 people with established psychosis recruited as part of the Improving\ud physical health and reduc…

AdultMalePsychosismedicine.medical_specialtyAdolescentmedia_common.quotation_subjectmedicine.medical_treatmentPopulationAddictionPhysical healthComorbiditySubstance useCigarette SmokingNicotineYoung AdultmedicineHumanseducationPsychiatryPsychoticGeneral PsychologyRandomized Controlled Trials as Topicmedia_commonFirst episodeeducation.field_of_studybusiness.industryAddictionSmokingTobacco Use DisorderGeneral Medicinemedicine.diseaseUnited KingdomPsychiatry and Mental healthPsychotic DisordersSchizophreniaCohortSchizophreniaSmoking cessationFemalebusinessmedicine.drug
researchProduct

Vitamin D and clinical symptoms in First Episode Psychosis (FEP): A prospective cohort study

2019

BACKGROUND: There is a paucity of longitudinal research investigating vitamin D in people with early psychosis.METHOD: Vitamin D levels were measured in 168 patients (64% (n = 108) male, mean age 29.3 (9.8) years) with first episode psychosis (FEP), along with measures of clinical state at baseline and at 12 months follow up. We assessed the a) cross sectional, and; b) longitudinal relationships between continuous and categorical 25-hydroxyvitamin D (25(OH)D) levels and clinical symptoms at first contact for psychosis and at 12 months.RESULTS: In FEP, 80% (n = 134) at baseline, and 76% at 12 months follow up, had suboptimal vitamin D levels (<20 ng/ml). Suboptimal levels of 25 (OH) D at …

AdultMalemedicine.medical_specialtyPsychosisCognitiveCross-sectional studyYoung Adult03 medical and health sciences0302 clinical medicineInternal medicineFirst episode psychosismedicineVitamin D and neurologyHumansLongitudinal StudiesProspective Studies25-hydroxyvitamin D (25(OH)D)Vitamin DYoung adultProspective cohort studyBiological PsychiatryNegative symptombusiness.industryFEPPsychosismedicine.disease030227 psychiatryPsychiatry and Mental healthCross-Sectional StudiesPsychotic DisordersSchizophreniaLongitudinalSchizophreniaFemaleNegative symptomsbusiness030217 neurology & neurosurgerySchizophrenia Research
researchProduct